Add BrightSurf on Google Email

Killing cancer cells with RNA therapeutics

In a mouse study, researchers successfully used RNA micelles to shrink metastasized tumors in lungs by delivering chemotherapy drugs and an RNA molecule that blocks cancer survival. The treatment significantly reduced tumor growth and improved outcomes for mice with colorectal cancer lung metastasis.

SourceOhio State University·JournalAdvanced Functional Materials·DateFeb 6, 2026

Role of OXCT1 in colorectal cancer liver metastasis

Researchers found OXCT1 to be a key regulator of colorectal cancer liver metastasis, with low expression linked to increased metastasis. OXCT1 suppression promotes oncogenic signaling through the CDK8/beta-catenin complex, highlighting its potential as a novel therapeutic target and prognostic biomarker.

SourceCompuscript Ltd·JournalGenes & Diseases·DateFeb 3, 2026

Study identifies PARG as a new target to enhance chemotherapy in colorectal cancer

A study led by researchers from the Germans Trias i Pujol Research Institute has identified PARG as a new target to enhance chemotherapy in colorectal cancer. Inhibition of PARG significantly increases the cytotoxic effect of chemotherapy, leading to enhanced cell death and apoptosis in different colorectal cancer models.

SourceGermans Trias i Pujol Research Institute·JournalClinical and Translational Medicine·TypeExperimental study·DateJan 28, 2026

Leading cancer deaths in people younger than 50 years

Cancer mortality rates have decreased for breast cancer and leukemia, despite increasing incidence, while colorectal cancer has become the leading cause of death among US young adults. Colorectal cancer surpasses lung, breast, and prostate cancers as the leading cancer-related death in people under 50 years old.

SourceJAMA Network·JournalJAMA·DateJan 22, 2026

Immune-targeting vaccine shows promise intercepting cancer in patients with Lynch Syndrome

Researchers found that NOUS-209 safely stimulated the immune system to target precancerous and cancerous cells in individuals with Lynch Syndrome, providing early evidence of its potential to intercept cancer before it develops. The vaccine-induced T cells were able to kill tumor cells and showed signs of long-lasting immune memory.

Deep learning model trained with stage II colorectal cancer whole slide images identifies features associated with risk of recurrence – with higher success rate than clinical prognostic parameters

A deep learning model trained on stage II colorectal cancer whole slide images accurately identified features linked to recurrence risk. The study found the model surpassed clinical prognostic parameters in predicting patient outcomes.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateJan 13, 2026

City of Hope experts available to provide insight on the American Cancer Society’s new ‘Cancer Statistics, 2026’ report

The American Cancer Society's new 'Cancer Statistics, 2026' report reveals a historic milestone: US cancer survivorship has reached a record 70%, driven by major gains in cancers once considered difficult to treat. However, the report also highlights persistent disparities, concerning increases in cancer among women and younger adults.

SourceCity of Hope·JournalCA A Cancer Journal for Clinicians·DateJan 13, 2026

Subtyping colorectal cancer

Researchers at Kyoto University identified five molecular subtypes of colorectal cancer stem cells and developed a practical prognostic indicator, the general colorectal cancer signature (GCS), to predict patient outcomes. The GCS was validated with a novel orthotopic xenograft mouse model and showed promising clinical significance.

SourceKyoto University·JournalCancer Science·TypeObservational study·DateDec 18, 2025

Mucosal virome and host transcriptome interactions reveal viral influence in colorectal polyp development

This study reveals significant viral-host interactions in colorectal polyps, identifying specific viruses associated with oncogenic and tumor-suppressive transcriptomic profiles. The findings suggest that viral activity contributes to early neoplastic transformation, challenging the traditional view of viruses as mere bystanders.

SourceFirst Hospital of Jilin University·JournaleGastroenterology·DateNov 30, 2025

Colorectal cancer screenings remain low for people ages 45 to 49 despite guideline change

Researchers found that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the USPSTF lowered the recommended screening age to 45. Despite investigating unmet social needs, no significant differences were found in testing uptake for this early midlife cohort.

SourceUniversity of California - Los Angeles Health Sciences·JournalJNCI Journal of the National Cancer Institute·TypeData/statistical analysis·DateNov 18, 2025

Study finds adults who consumed more ultra-processed foods had higher rates of precursors of early-onset colorectal cancer

A study of nearly 30,000 female nurses found that consuming more ultra-processed foods was associated with a 45% higher risk of developing adenomas, precursors to early-onset colorectal cancer. The study's findings support the importance of reducing ultra-processed food intake as a strategy to mitigate the rising burden of early-onset ...

SourceMass General Brigham·JournalJAMA Oncology·TypeObservational study·DateNov 13, 2025

Combination of immunotherapy and targeted therapy improves survival for patients with advanced colorectal cancer

Researchers found that combining zanzalintinib, a targeted therapy drug, with atezolizumab, an immune checkpoint inhibitor, improved survival rates by 20% compared to standard treatment regorafenib. The new combination also delayed cancer progression and showed promising results in patients with metastatic colorectal cancer.

UC Irvine researchers invent bioelectronic-integrated artificial colon for disease studies, drug screening

Researchers at UC Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The model shows promising results in detecting resistance to chemotherapy drugs, making it a potential alternative to traditional animal testing.

SourceUniversity of California - Irvine·JournalAdvanced Science·TypeMeta-analysis·DateOct 15, 2025

Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers

A new study published in Diabetes, Obesity and Metabolism found that weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes. The study analyzed data from over 180,000 people and found a significant reduction in cancer incidence ...

SourceUniversity of Leicester·JournalDiabetes Obesity and Metabolism·TypeObservational study·DateSep 24, 2025